|
|
 |
|
Viewing report
|
|
|
|
Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries
Frost & Sullivan, March 2011, Pages: 82
The aim of this research service is to present an overview of the pharmaceutical distribution channels in Malawi, Mauritius, and Zambia. The research service also provides an overview of the structure of the healthcare industry; it elaborates on the sources of healthcare funding; the research service further provides data on healthcare expenditure, the process of pharmaceutical regulation, and the distribution and procurement of pharmaceuticals. The healthcare industry covers a broad spectrum of segments however, for the purposes of this research service, the focus is on the pharmaceutical industry. Distributors identified to be key in the supply of pharmaceuticals in the different territories are profiled according to various metrics
Research Overview
This Frost & Sullivan research service titled Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries provides an analysis of the pharmaceutical distribution landscape in key countries of the Southern African Development Community (SADC) region. It also offers company profiles of major distributors. In this research, Frost & Sullivan's expert analysts thoroughly examine the following countries: Mauritius, Malawi and Zambia.
Market Overview
Reliance on Imported Generics Continues
The demand for medicines to treat communicable and non-communicable conditions has spurred the growth of the pharmaceutical industry in Mauritius, Malawi and Zambia. However, local pharmaceutical manufacturing in these countries is limited with a heavy reliance on imported medicines. As demand for medicines continues to increase in these key countries of the Southern African Development Community (SADC) region, more lucrative opportunities are set to emerge for pharmaceutical importers.
“Growth in the pharmaceutical industry in this region will be driven by the availability of low cost generic medicines for communicable and non- communicable diseases,” notes the analyst of this research. “The majority of pharmaceutical imports into these countries are generic medicines from India and South Africa.” The high burden of infectious disease is motivating strong investments in anti-infective treatments. At the same time, increased private sector investment is boosting the demand for branded ethical products.
Distributors to Focus on Improving Presence in More Geographic Locations
Access to medical insurance in this region is limited with a significant proportion of the population paying for medicines out-of-pocket. As this market is price sensitive, more consumers opt to buy generic medicines because they are more affordable. “A large proportion of the population in this region, particularly in Malawi resides in the rural areas,” adds the analyst. “Poor infrastructure, particularly the road network, poses challenges for pharmaceutical supply into these areas.”
Remote areas often experience delays in the supply of pharmaceuticals due to the underdeveloped road network. Thus, it is important that distributors of pharmaceuticals have a presence in different geographic locations in each country to minimise such delays. “Several pharmaceutical distributors have in addition to a central urban warehouse, other warehouses in less urban regions to ensure that more remote areas are serviced timely,” concludes the analyst.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following countries in this research:
- Mauritius
- Malawi
- Zambia
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
